Brucellosis in the etiology of XXXX : case report.

@entity1 @entity632 @entity3377 @entity5 @entity900 @entity786 @entity4509 @entity3403 @entity2879 @entity3639 @entity1398 @entity206 @entity6467 @entity207 @entity1499 @entity221 @entity1487
Brucellosis is one of the leading diseases in the differential diagnosis of @entity221 of unknown origin in some parts of the world. It can lead to treatment failure because of slow growth in blood cultures and late appearance of signs and symptoms in @entity1 with @entity1398 who were unresponsive to empirical antibiotic treatment. During the last year in our oncology unit adjuvant chemotherapy was given to 3 @entity1 with breast (n=1) and @entity5 (n=2) and @entity1398 was seen after the first course of chemotherapy ( @entity786 , @entity1499 , @entity1487 , @entity2879 , @entity632 , and @entity900 ) in all 3 @entity1 . Cefepime and @entity4509 were commenced but the @entity221 continued. Prior to antifungal treatment, the @entity1 were re-evaluated because of the history of unpasteurized milk ingestion without overt signs and symptoms. Serum agglutination tests of @entity3377 were performed and were 1:640 in two @entity1 and 1:320 in the third. @entity6467 was identified only in one case although multiple blood cultures were taken from all 3 patients. Empiric antibiotic treatment was stopped and @entity3639 1 g/day (10 days), @entity3403 200 mg/day (28 days), @entity206 320 mg and @entity207 1600 mg/day (28 days) were given. Although @entity1398 continued, @entity221 subsided in 3 days. Due to high incidence of @entity3377 in some geographic areas, especially in the Middle East, @entity3377 should be kept in mind in the differential diagnosis of @entity1398 .
